Abstract
Abstract
Background
HIV outbreaks among people who inject drugs (PWID) and experience homelessness are increasing across the USA. Despite high levels of need, multilevel barriers to accessing antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention persist for this population. The Boston Health Care for the Homeless Program (BHCHP) initiated a low-threshold, outreach-based program to support engagement in PrEP services among PWID experiencing homelessness.
Methods
To inform dissemination efforts, we explored patient and provider perspectives on key program components. From March to December 2020, we conducted semi-structured qualitative interviews with current and former BHCHP PrEP program participants and prescribers, patient navigators, and outreach workers (i.e., providers). Thematic analysis explored perspectives on key program components.
Results
Participants (n = 21) and providers (n = 11) identified the following five key components of BHCHP’s PrEP program that they perceived to be particularly helpful for supporting patient engagement in PrEP services: (1) community-driven PrEP education; (2) low-threshold, accessible programming including same-day PrEP prescribing; (3) tailored prescribing supports (e.g., on-site pharmacy, short-term prescriptions, medication storage); (4) intensive outreach and navigation; and (5) trusting, respectful patient-provider relationships.
Discussion
Findings suggest that more patient-centered services formed the basis of BHCHP’s innovative, successful PrEP program. While contextual challenges including competing public health emergencies and homeless encampment “sweeps” necessitate ongoing programmatic adaptations, lessons from BHCHP’s PrEP program can inform PrEP delivery in a range of community-based settings serving this population, including syringe service programs and shelters.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Broz D, Carnes N, Chapin-Bardales J, et al. Syringe services programs' role in ending the HIV epidemic in the U.S.: why we cannot do it without them. Am J Prev Med 2021;61(5 Suppl 1):S118-S29. https://doi.org/10.1016/j.amepre.2021.05.044 [published Online First: Epub Date]|.
2. Handanagic S, Finlayson T, Burnett JC, Broz D, Wejnert C, National HIVBSSG. HIV infection and HIV-associated behaviors among persons who inject drugs - 23 metropolitan statistical areas, United States, 2018. MMWR Morb Mortal Wkly Rep 2021;70(42):1459-65. https://doi.org/10.15585/mmwr.mm7042a1 [published Online First: Epub Date]|.
3. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012;17(4). Available at: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-17-4.pdf. Accessed May 2, 2022.
4. Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011-15: a modelling study. Lancet HIV 2018;\(10):e569-e77. https://doi.org/10.1016/S2352-3018(18)30176-0 [published Online First: Epub Date]|.
5. Cranston K, Alpren C, John B, et al. Notes from the field: HIV diagnoses among persons who inject drugs—Northeastern Massachusetts, 2015–2018. MMWR Morb Mortal Wkly Rep 2019;68(10):253
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献